Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia
- PMID: 3154530
- DOI: 10.1016/0920-9964(88)90025-4
Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia
Abstract
A sensitive radioimmunoassay was developed to determine the steady-state, fixed-dose pharmacokinetic profile of fluphenazine decanoate in nine outpatients. To see if neuroleptic blood levels measured by this assay correlated with a clinical event, we performed a cross-sectional study of fluphenazine blood levels in 11 patients with and 17 patients without tardive dyskinesia. The results do not support the hypothesis that fluphenazine decanoate serum levels correlate with TD occurrence.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
